BCIQ Marketing

Pipeline Analyst

A new Biocentury entirely reimagined for mobile, tablet and and desktop. With content and tools designed to inform and empower, wherever work takes you.

Financial Analyst

A new Biocentury entirely reimagined for mobile, tablet and and desktop. With content and tools designed to inform and empower, wherever work takes you. これわ日本語

Company Analyst

A new Biocentury entirely reimagined for mobile, tablet and and desktop. With content and tools designed to inform and empower, wherever work takes you.

Deal Analyst

A new Biocentury entirely reimagined for mobile, tablet and and desktop. With content and tools designed to inform and empower, wherever work takes you.

4 Fully Integrated, Online Databases
  • 4 Fully Integrated, Online Databases

     

    BioCentury's BCIQ is unlike any other business intelligence and research tool on the market. It combines over 24 years of BioCentury's leading analysis of the biopharma industry with four easy-to-use, fully integrated modules. The data are fully vetted and meticulously maintained. Quite simply, BCIQ is the most accurate, in-depth tool for your research and business intelligence needs.

    BCIQ 4 takes biopharma business intelligence and research to the next level with a Deals module that seamlessly integrates with BCIQ's existing pipeline, financial and company modules. 

    Request a Free BCIQ Trial

    View the BCIQ Fact Sheet

     


    Deal Analyst

    View content-rich deal profiles and in-depth updates

    Create Top 10 lists of deal makers

    Evaluate key financial metrics of deals gathered through primary source research

    Research M&A share prices, premiums and private company financing histories 

    Request a Free BCIQ Trial

     

    Pipeline Analyst

    Identify new licensing opportunities

    Build a competitive landscape of any disease category

    Access partner company pipelines and financial histories

    Discover unpartnered compounds and emerging companies

    Request a Free BCIQ Trial

     

    Financial Analyst

    Pinpoint new investment opportunities

    Analyze corporate financials, fundraising and stock summaries

    Find investors and VCs active in your therapeutic area

    Research over $500 billion in financings

    Request a Free BCIQ Trial

     

     

    Company Analyst

    View detailed profiles and analysis of life science companies

    Track competitors' activities

    View deal flow by company

    Create reports on deals and clinical histories

    Request a Free BCIQ Trial

Pipeline Analyst

A new Biocentury entirely reimagined for mobile, tablet and and desktop. With content and tools designed to inform and empower, wherever work takes you.

  • BioCentury
  • BC Innovations
  • BC Week In Review
  • BC Extra
  • Special Sections
Pipeline Analyst
  • Subhead

    BioCentury's weekly flagship publication provides analysis, interpretation and commentary on biopharma industry corporate performance, product discovery and development, emerging companies and technologies, regulatory events and innovation, public policy and financial markets.

    Trial Sign Up

  • Biocentury

    BioCentury has pioneered the creation of turf-neutral, independent venues for the pharmaceutical, biotech .

    SEE A SAMPLE BIOCENTURY >
  • BC INNOVATIONS

    BioCentury has pioneered the creation of turf-neutral, independent venues for the pharmaceutical, biotech .

    SEE A SAMPLE BC INNOVATIONS >
  • BC Week IN Review

    BioCentury has pioneered the creation of turf-neutral, independent venues for the pharmaceutical, biotech .

    SEE A SAMPLE BC WEEK IN REVIEW >
  • BC Extra

    BioCentury has pioneered the creation of turf-neutral, independent venues for the pharmaceutical, biotech .

    SEE A SAMPLE BC EXTRA >
  • Subhead

    BioCentury and Innovations are available in pdf and all our publications 
    are optimized for PC, mobile and tablet.

Financial Analyst

A new Biocentury entirely reimagined for mobile, tablet and and desktop. With content and tools designed to inform and empower, wherever work takes you. これわ日本語

  • New York
  • Europe
  • San Francisco
  • China
Financial Analyst
  • Subhead

    BioCentury's weekly flagship publication provides analysis, interpretation and commentary on biopharma industry corporate performance, product discovery and development, emerging companies and technologies, regulatory events and innovation, public policy and financial markets.

    Trial Sign Up

  • Sponsorship Opportunities

    BioCentury has pioneered the creation of turf-neutral, independent venues for the pharmaceutical, biotech and investment communities to network and conduct business. Our conferences are recognized for the quality of the presenting companies and their audiences.

    LEARN MORE  >

    Presenter  Opportunities

    BioCentury has pioneered the creation of turf-neutral, independent venues for the pharmaceutical, biotech and investment communities to network and conduct business.

    LEARN MORE  >

Company Analyst

A new Biocentury entirely reimagined for mobile, tablet and and desktop. With content and tools designed to inform and empower, wherever work takes you.

  • BioCentury
  • BC Innovations
  • BC Week In Review
  • BC Extra
Company Analyst
  • Subhead

    BioCentury's weekly flagship publication provides analysis, interpretation and commentary on biopharma industry corporate performance, product discovery and development, emerging companies and technologies, regulatory events and innovation, public policy and financial markets.

    Trial Sign Up

  • Biocentury

    BioCentury is the essential source of intelligence for a global audience of biotech and pharmaceutical company professionals, investors, researchers, service providers and industry stakeholders who demand deep industry knowledge, data-driven analysis, independent perspective and a commitment to accuracy. Our insight, trusted reporting and in-depth analysis are built on independent, objective surveillance of the biotechnology sector, producing the industry's most respected journals and data solution resources, since 1993.

    SEE A SAMPLE BIOCENTURY >
  • BC INNOVATIONS

    BioCentury Innovations (formerly SciBX) identifies commercially promising translational science and assesses the next steps required to develop the technology. Every week, BioCentury's business and science editors analyze life science research published around the globe to provide the Innovations audience in R&D, business development, academia and the venture capital community with an early lead on fresh science with investment potential.

    SEE A SAMPLE BC INNOVATIONS >
  • BC Week IN Review

    Provides a weekly compendium of biopharma deals, clinical and regulatory events, and financial transactions.

    SEE A SAMPLE BC WEEK IN REVIEW >
  • BC Extra

    Published every business day to be viewed on mobile devices or online, providing busy executives and investors with a concise report of key industry news events that are selected for importance by BioCentury's experienced editors.

    SEE A SAMPLE BC EXTRA >
  • Subhead

    BioCentury and Innovations are available in pdf and our new online experience is optimized for desktop, tablet and mobile.

Deal Analyst

A new Biocentury entirely reimagined for mobile, tablet and and desktop. With content and tools designed to inform and empower, wherever work takes you.

  • BioCentury
  • BC Innovations
  • BC Week In Review
  • BC Extra
  • Special Sections
Deal Analyst
  • Subhead

    BioCentury's weekly flagship publication provides analysis, interpretation and commentary on biopharma industry corporate performance, product discovery and development, emerging companies and technologies, regulatory events and innovation, public policy and financial markets.

    Trial Sign Up

  • Biocentury

    BioCentury has pioneered the creation of turf-neutral, independent venues for the pharmaceutical, biotech .

    SEE A SAMPLE BIOCENTURY >
  • BC INNOVATIONS

    BioCentury has pioneered the creation of turf-neutral, independent venues for the pharmaceutical, biotech .

    SEE A SAMPLE BC INNOVATIONS >
  • BC Week IN Review

    BioCentury has pioneered the creation of turf-neutral, independent venues for the pharmaceutical, biotech .

    SEE A SAMPLE BC WEEK IN REVIEW >
  • BC Extra

    BioCentury has pioneered the creation of turf-neutral, independent venues for the pharmaceutical, biotech .

    SEE A SAMPLE BC EXTRA >
  • Subhead

    BioCentury and Innovations are available in pdf and all our publications 
    are optimized for PC, mobile and tablet.